PTX-200

triciribine · Prescient Therapeutics, Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PTX-200, covering 2024-04-05 to 2024-04-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of PTX-200 (Triciribine) Plus Cytarabine in Refractory or Relapsed Acute Leukemia [Phase 1, Phase 2]